During an oral Spotlight Presentation, Codexis unveiled the successful end-to-end enzymatic synthesis of an entire approved siRNA therapeutic asset, inclisiran. Codexis enzymatically synthesized the ...
To ensure big data is used to influence outcomes that are meaningful to the nursing profession, nurse executives need to act as data visionaries and architects. But how? Have you ever found yourself ...
Artificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, ...
Currently, deep learning is the most important technique for solving many complex machine vision problems. State-of-the-art deep learning models typically contain a very large number of parameters ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Synthesis AI, a San Francisco-based startup specializing in synthetic ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
The diagram illustrates the interplay among data acquisition, machine learning, and experiment synthesis. Physical models such as thermodynamics and kinetics can be integrated into ML models as expert ...
REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results